Abstract: The present disclosure provides a pharmaceutical composition for preventing or treating cancer comprising a NUPR1 isoform A inhibitor as an active ingredient, a composition for diagnosing or predicting prognosis of cancer comprising an agent for measuring an expression or activity level of a NUPR1 isoform A, a kit for diagnosing or predicting prognosis of cancer comprising the composition, a method for screening a substance for inhibiting cancer cell proliferation or metastasis, a method for providing information for cancer cell proliferation or metastasis, a food composition for preventing or improving cancer comprising a NUPR1 isoform A inhibitor as an active ingredient, and a feed composition for preventing or improving cancer comprising a NUPR1 isoform A inhibitor as an active ingredient.

Abstract: A lubricator includes a pump body configured to include a cylinder, an inlet passage, a first outlet passage and a second outlet passage, a piston configured to include an inlet port, a circumferential groove and an inner passage, and inserted into the cylinder, first to fourth check valves provided on the inlet side of the inlet passage, the outlet sides of the first and second outlet passages and the inner passage of the piston, a lubricant containing unit connected to the first check valve, and a piston driving unit configured to reciprocate the piston.

Abstract: A lubricator includes a pump body configured to include a cylinder, an inlet passage, a first outlet passage and a second outlet passage, a piston configured to include an inlet port, a circumferential groove and an inner passage, and inserted into the cylinder, first to fourth check valves provided on the inlet side of the inlet passage, the outlet sides of the first and second outlet passages and the inner passage of the piston, a lubricant containing unit connected to the first check valve, and a piston driving unit configured to reciprocate the piston.